February 2007 Volume 3, Issue 2

Volume 3, Issue 2 | February 2007

February 2007

In this Issue

News Briefs

Informatics

Drug Discovery News Placeholder Image

More exacting extracting

Reel Two, ACD/Labs collaborate on chemical name-to-structure project
Drug Discovery News Placeholder Image

Decision to integrate

GeneGo\'s MetaCore, MetaDrug integrted with Spotfire\'s DecisionSite
Drug Discovery News Placeholder Image

Image is everything

BioImagene to bundle imaging products with HP servers for better customer efficiency
Drug Discovery News Placeholder Image

UCSD, Brown release InvChecker microinversion software

Microinversion software release identification of genomic variation

Automation & Instrumentation

Drug Discovery News Placeholder Image

Trading their array of technology

Oxford Gne Technology and NimbleGen Systems secure cross-licensing deal
Drug Discovery News Placeholder Image

Site on scene lab management

SiteMAX program puts Beckman Coulter in role of managing customers\' equipment.
Drug Discovery News Placeholder Image

By-the-slice MS imaging

Protein Discovery rolls out MALDI mass spec imaging by-the-slice service
Drug Discovery News Placeholder Image

Invitrogen gives clients ability to bag it up

Company will supply cell cultures in Wave bioreactor bags

Genomics & Proteomics

Drug Discovery News Placeholder Image

Forget me not

Ablynx and Boehringer Ingelheim sign deal to discover new Alzheimer\'s treatments
Drug Discovery News Placeholder Image

A new pitch to stop ALS

ALS Therapy Development Institute (ALS TDI) funds new $36 million, three-year study
Drug Discovery News Placeholder Image

New tool for nucleosome charting

Dana-Farber researchers recently developed a new method of charting nucleosomes throughout the human genome.
Drug Discovery News Placeholder Image

Canadian scientists release first draft of human metabolome

University of Alberta Researchers cap the three-year $7.5 million Human Metabolome Project

Research & Development

Drug Discovery News Placeholder Image

A natural fit

Bristol-Meyers Squibb turns to Albany Molecular Research for natural product collaboration
Drug Discovery News Placeholder Image

Raising the yellow flag

FDA issues precautions to pharma companies over testing at two MDS labs
Drug Discovery News Placeholder Image

8-million compound library

Wyeth taps Pharmacopeia data for immunology and inflammation work
Drug Discovery News Placeholder Image

Ardea Biosciences: Drug discovery from the ashes of IntraBiotics

The company formerly known as IntraBiotics Pharmaceuticals, Inc., is rebuilding itself as Ardea Biosciences, Inc., after acquiring intellectual property, data, inventory, and equipment from Valeant Pharmaceuticals International and hiring a new management team.
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue